Clinical Trial Update: Clinical Study of Radiotherapy Combined With Donafenib for Neoadjuvant Treatment of Patients With HCC With Portal Vein Carcinoma Thrombosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating radiotherapy plus donafenib as neoadjuvant therapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Donafenib (donafenib)
• Radiotherapy

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: HCC, Chemotherapy Effect | Phase 4 | Status: UNKNOWN